AnaptysBio Inc buy JPMorgan Chase & Co.
Start price
12.11.24
/
50%
€20.20
Target price
12.11.25
€62.23
Performance (%)
37.62%
End price
13.11.25
€27.80
Summary
This prediction ended on 13.11.25 with a price of €27.80. With a performance of 37.62% the BUY prediction by JPMorgan_Chase___Co_ was a big success. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| AnaptysBio Inc | 0.516% | 0.516% | 183.081% |
| iShares Core DAX® | -1.283% | 4.209% | 7.084% |
| iShares Nasdaq 100 | -3.338% | -1.744% | 26.177% |
| iShares Nikkei 225® | -4.286% | -1.621% | 44.320% |
| iShares S&P 500 | -2.311% | -0.096% | 20.823% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at JPMorgan Chase & Co. from $75.00 to $66.00. They now have an "overweight" rating on the stock.
Ratings data for ANAB provided by MarketBeat
In the thread Trading AnaptysBio Inc
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten